: OCUL

Ocular Therapeutix Inc (NASDAQ: OCUL)

Ocular Therapeutix, Inc., a biopharmaceutical company, focuses on the development and commercialization of therapies for diseases and conditions of the eye using its proprietary hydrogel platform technology in the United States.